Correlation Between Revolution Medicines and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Revolution Medicines and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Zentalis Pharmaceuticals.
Diversification Opportunities for Revolution Medicines and Zentalis Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Revolution and Zentalis is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Revolution Medicines and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.7 times more return on investment than Zentalis Pharmaceuticals. However, Revolution Medicines is 1.43 times less risky than Zentalis Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.03 per unit of risk. If you would invest 2,380 in Revolution Medicines on September 2, 2024 and sell it today you would earn a total of 3,405 from holding Revolution Medicines or generate 143.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revolution Medicines vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Revolution Medicines |
| Zentalis Pharmaceuticals |
Revolution Medicines and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revolution Medicines and Zentalis Pharmaceuticals
The main advantage of trading using opposite Revolution Medicines and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
| Zentalis Pharmaceuticals vs. Tff Pharmaceuticals | Zentalis Pharmaceuticals vs. Eliem Therapeutics | Zentalis Pharmaceuticals vs. Inhibrx | Zentalis Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets |